187 related articles for article (PubMed ID: 11944925)
21. Potent and selective peptide agonists of alpha-melanocyte stimulating hormone (alphaMSH) action at human melanocortin receptor 5; their synthesis and biological evaluation in vitro.
Bednarek MA; MacNeil T; Tang R; Fong TM; Angeles Cabello M; Maroto M; Teran A
Chem Biol Drug Des; 2007 May; 69(5):350-5. PubMed ID: 17539827
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship of cyclic peptide penta-c[Asp-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys]-NH(2) at the human melanocortin-1 and -4 receptors: His(6) substitution.
Cheung AW; Danho W; Swistok J; Qi L; Kurylko G; Rowan K; Yeon M; Franco L; Chu XJ; Chen L; Yagaloff K
Bioorg Med Chem Lett; 2003 Apr; 13(7):1307-11. PubMed ID: 12657270
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.
Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055
[TBL] [Abstract][Full Text] [Related]
24. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
26. Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold.
Ballet S; Mayorov AV; Cai M; Tymecka D; Chandler KB; Palmer ES; Rompaey KV; Misicka A; Tourwé D; Hruby VJ
Bioorg Med Chem Lett; 2007 May; 17(9):2492-8. PubMed ID: 17314042
[TBL] [Abstract][Full Text] [Related]
27. Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.
Bednarek MA; MacNeil T; Kalyani RN; Tang R; Van der Ploeg LH; Weinberg DH
J Med Chem; 2001 Oct; 44(22):3665-72. PubMed ID: 11606131
[TBL] [Abstract][Full Text] [Related]
28. Structural Insights into Selective Ligand-Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists.
Cai M; Marelli UK; Mertz B; Beck JG; Opperer F; Rechenmacher F; Kessler H; Hruby VJ
Biochemistry; 2017 Aug; 56(32):4201-4209. PubMed ID: 28715181
[TBL] [Abstract][Full Text] [Related]
29. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
[TBL] [Abstract][Full Text] [Related]
30. Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.
Mayorov AV; Cai M; Chandler KB; Petrov RR; Van Scoy AR; Yu Z; Tanaka DK; Trivedi D; Hruby VJ
J Med Chem; 2006 Mar; 49(6):1946-52. PubMed ID: 16539382
[TBL] [Abstract][Full Text] [Related]
31. Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.
Cai M; Marelli UK; Bao J; Beck JG; Opperer F; Rechenmacher F; McLeod KR; Zingsheim MR; Doedens L; Kessler H; Hruby VJ
J Med Chem; 2015 Aug; 58(16):6359-67. PubMed ID: 26218460
[TBL] [Abstract][Full Text] [Related]
32. Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.
Bednarek MA; MacNeil T; Tang R; Kalyani RN; Van der Ploeg LH; Weinberg DH
Biochem Biophys Res Commun; 2001 Aug; 286(3):641-5. PubMed ID: 11511108
[TBL] [Abstract][Full Text] [Related]
33. Analogs of lactam derivatives of alpha-melanotropin with basic and acidic residues.
Bednarek MA; MacNeil T; Kalyani RN; Tang R; Van der Ploeg LH; Weinberg DH
Biochem Biophys Res Commun; 2000 May; 272(1):23-8. PubMed ID: 10872798
[TBL] [Abstract][Full Text] [Related]
34. Solution structures of cyclic melanocortin agonists and antagonists by NMR.
Ying J; Kövér KE; Gu X; Han G; Trivedi DB; Kavarana MJ; Hruby VJ
Biopolymers; 2003; 71(6):696-716. PubMed ID: 14991679
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.
Cheung AW; Danho W; Swistok J; Qi L; Kurylko G; Rowan K; Yeon M; Franco L; Chu XJ; Chen L; Yagaloff K
Bioorg Med Chem Lett; 2003 Jan; 13(1):133-7. PubMed ID: 12467633
[TBL] [Abstract][Full Text] [Related]
36. Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors.
Wessells H; Hruby VJ; Hackett J; Han G; Balse-Srinivasan P; Vanderah TW
Neuroscience; 2003; 118(3):755-62. PubMed ID: 12710982
[TBL] [Abstract][Full Text] [Related]
37. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
39. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of a novel potent cyclic peptide MC4-ligand by ring-closing metathesis.
Wels B; Kruijtzer JA; Garner K; Nijenhuis WA; Gispen WH; Adan RA; Liskamp RM
Bioorg Med Chem; 2005 Jul; 13(13):4221-7. PubMed ID: 15876540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
